Table 1.
Demographic and clinical variables in the cohort examined for expression of circulating miRNAs
| Demographic and clinical variables | Mean (SD) (N=44) or N (%) |
|---|---|
| Age (years) | 62.50±9.60 |
| BMI | 29.92±4.76 |
| ALT (U/L) | 25.50±13.75 |
| AST (U/L) | 21.65±8.31 |
| GGT | 22.96±17.39 |
| WCC (103/μL) | 9.26±13.79 |
| Platelet (103/μL) | 215.91±48.51 |
| Glucose (mg/dL) | 137.12±92.47 |
| Triglycerides (mg/dL) | 113.40±53.60 |
| Total cholesterol (mg/dL) | 150.73±31.88 |
| LDL (mg/dL) | 80.90±28.21 |
| HDL (mg/dL) | 43.40±14.72 |
| Gender—male | 39 (88.6%) |
| Race—white | 40 (90.9%) |
| CAD with NAFLD | 32 (72.7%) |
Values are presented as mean and SD or percentages, where appropriate.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; CAD, coronary artery disease; GGT, γ-glutamyl transferase; HDL, high-density lipoprotein; LDL, low-density lipoprotein; miRNA, microRNA; NAFLD, non-alcoholic fatty liver disease; WCC, white cell count.